TITLE

Multicenter Double--Blind Study of Ticlopidine in the Treatment of Intermittent Claudication and the Prevention of its Complications

AUTHOR(S)
Arcan, J. C.; Blanchard, J.; Boissel, J. P.; Destors, J. M.; Panak, E.
PUB. DATE
September 1988
SOURCE
Angiology;Sep1988, Vol. 39 Issue 9, p802
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In this multicenter trial 169 patients with chronic intermittent claudication due to obstructive peripheral vascular disease were randomized in a double-blind fashion into two parallel groups receiving either 250 mg ticlopidine or placebo, twice daily. At entry, the two groups (83 ticlopidine, 86 placebo) were well matched for the major clinical features apart from an excess of women in the ticlopidine group. At six months, 167 patients were alive, 2 having died of malignant disease (1 from each group). At this stage, 39 patients from the ticlopidine group and 29 from the placebo group (p = 0.04) had increased their walking distance by more than 50% of baseline values. For the groups as a whole pain-free and total walking distance were greater in the ticlopidine group than in the placebo group (194 vs 124 meters, p = 0.03 and 236 vs 170 meters, p = 0.04, respectively). Two patients from the ticlopidine group vs 9 patients from the placebo group (p = 0.03) developed significant cardiovascular events during the study. These results indicate that ticlopidine has a beneficial effect both in the treatment of the symptoms and the prevention of vascular complications in patients with intermittent claudication.
ACCESSION #
16346228

 

Related Articles

  • LONG-TERM ANTICOAGULANT THERAPY IN THE TREATMENT OF INTERMITTENT CLAUDICATION. Milnés-López, Bernardo; Carrillo, Pedro; Toledo, Fernando; McCook, George // Angiology;Dec1957, Vol. 8 Issue 6, p534 

    Discusses the long-term anticoagulant therapy in the treatment of intermittent claudication. Evaluation of intermittent claudication; Effect of long continued anticoagulant therapy on intermittent claudication; Degree of improvement of the treatment.

  • The low down on claudicant leg pain. Targett, Steve // New Zealand Doctor;6/14/2006, p34 

    Presents information on claudicant leg pain. Description of the leg pain; Causes; Treatment.

  • A Botanical Compound, Padma 28, Increases Walking Distance in Stable Intermittent Claudication. Drabaek, Hans; Mehlsen, Jesper; Himmelstrup, Holger; Winther, Kaj // Angiology;Nov1993, Vol. 44 Issue 11, p863 

    Thirty-six patients with a median age of sixty-seven years and a median duration of intermittent claudication of five years were randomized to either active treatment with Padma 28 or placebo. The effect of treatment was quantified by measurements of systemic and peripheral systolic blood...

  • INTERMITTENT CLAUDICATION (ANGINA CRURIS). Samuels, Saul S. // Angiology;Aug1958, Vol. 9 Issue 4, p245 

    Provides information about intermittent claudication. Cause and pathogenesis; Signs and symptoms; Diagnosis and treatment;

  • NEW CLINICAL APPROACH TO THE MANAGEMENT OF INTERMITTENT CLAUDICATION (ANGINA CRURIS). Samuels, Saul S.; Shaftel, Herbert E. // Angiology;Dec1958, Vol. 9 Issue 6, p378 

    Examines a clinical approach to the management of intermittent claudication or angina cruris. Consideration of plethysmographic studies in judging the effect of vasodilating drugs on the peripheral circulation; Importance of supplementing vasodilators with tranquilizers; Description of the...

  • Randomized Reliability Study Evaluating Constant-load and Graded-exercise Treadmill Test for Intermittent Claudication. Cachovan, Milan; Rogatti, Waltraud; Woltering, Franz; Creutzig, Andreas; Diehm, Curt; Heidrich, Heinz; Scheffler, Peter // Angiology;Mar1999, Vol. 50 Issue 3, p193 

    The aim of this randomized study was to compare the reliability of the treadmill test at constant-load (C-test, 3 km/hr; fixed grade of 12%) recommended in Germany with that of the graded-exercise test (G-test, 3 km/hr; increase in grade of 3.5% every 3 minutes) propagated in the United States....

  • Blood Viscosity During Long-Term Treatment with Ticlopidine in Patients with Intermittent Claudication. A Double-Blind Study. Fagher, Birger; Persson, Sylvi; Persson, Gunnar; Larsson, Hans // Angiology;Apr1993, Vol. 44 Issue 4, p300 

    The aim was to test within a randomized, double-blind trial whether the antiaggregant drug ticlopidine might reduce blood viscosity as has been claimed. Sixteen patients with intermittent claudication were studied before and after three years of treatment with ticlopidine, 500 mg/day, or...

  • New developments in intermittent claudication. Stansby, Gerard // Pulse;4/30/2005, Vol. 65 Issue 17, p57 

    The article cites new developments in intermittent claudication (IC). Background IC is often the first symptom of peripheral arterial disease and is usually due to widespread atherosclerosis. However, IC symptoms often go unreported by patients since they assume the cramp-like pain on walking to...

  • A TWO-STEP TEST OF EXERCISE TOLERANCE IN INTERMITTENT CLAUDICATION. Kissin, Milton; Steix, Julius J.; Adleman, Ralph J. // Angiology;Apr1950, Vol. 1 Issue 2, p141 

    A two-step stair climbing test was found to be a satisfactory and convenient measure of exercise tolerance in intermittent claudication. The patient walked back and forth over a set of steps until pain appeared in the leg. The number of trips made over the steps was recorded as the exercise...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics